Type A - Houlihan Lokey, Inc. (HLI) 20261101 Stock Analysis

📅 Houlihan Lokey Key Upcoming Events

• December 01, 2026 Quarterly Dividend Ex-Dividend Date (Estimated)
  • Description: The indicated quarterly dividend is $0.70 per share, equivalent to $2.80 annually. The projected ex-dividend date reflects the current dividend calendar and remains subject to the company’s final declaration.
• January 27, 2027 Q3 FY2027 Earnings Release (Estimated)
  • Description: The date is based on financial-calendar projections and Houlihan Lokey’s historical late-January reporting pattern; the company has not officially confirmed it and the date may change. Investors will focus on M&A completion activity, restructuring fees, compensation discipline, and recovery from the weak first quarter of FY2027.

🏢 Step 1: Houlihan Lokey Company Overview & Business Model

Q1-A1. What is Houlihan Lokey?

• Company Name (Ticker): Houlihan Lokey, Inc. (HLI)
• Sector: Financials
• Exchange: NYSE
• Founded: March 07, 1972
• Listing Date: August 13, 2015
• Fiscal Year End: March
• Headquarters: United States, Los Angeles
• CEO: Scott Adelson
• Market Cap: $9.58B
• Shares Outstanding: 69.42M
• Current Stock Price: $138.00
• Annual Dividend Yield: 2.03%
• Ex-dividend Date: December 01, 2026 (ET)
• As-of: November 01, 2026 (ET)

Q1-A2. How Does Houlihan Lokey Make Money?

• Transaction-Based Financial Advisory Fees: Houlihan Lokey earns advisory fees from corporations, private equity sponsors, creditors, and other institutions seeking advice on mergers, acquisitions, financing transactions, restructurings, and business valuations.
• M&A Advisory: The firm advises buyers and sellers on transactions, generating substantial fees when deals are completed. Revenue depends on transaction volume, deal complexity, advisory mandates, and successful execution.
• Financial Restructuring Advisory: The firm advises distressed companies and creditor groups on recapitalizations, debt negotiations, and bankruptcy-related transactions. Demand can increase when credit conditions deteriorate.
• Financial and Valuation Advisory: The firm provides valuation opinions, financial analyses, and transaction-related advisory services. This segment offers a somewhat more recurring demand base than M&A completion fees.
• Capital-Light Economics: The primary productive assets are experienced bankers, client relationships, sector expertise, and transaction execution capabilities. Compensation is the dominant operating expense rather than physical infrastructure.
• Revenue Diversification: Corporate Finance benefits from healthy transaction markets, while Financial Restructuring can partially offset weaker M&A activity during periods of credit stress. The two businesses are complementary but do not fully eliminate cyclicality.

Q1-A3. Houlihan Lokey’s Revenue Segments & Core Income Sources

• Corporate Finance — Approximately 66.2% of TTM Revenue:
  • Revenue for the twelve months ended September 2026 was approximately $1.69B out of consolidated revenue of $2.56B.
  • The business includes M&A advisory and capital solutions, with particular strength in middle-market transactions and financial sponsor relationships.
  • During Q2 FY2027, revenue increased approximately 10% YoY to $481.00M, representing 69.5% of quarterly revenue.
  • This segment offers the greatest earnings leverage to improving M&A activity but also generates the largest exposure to transaction-cycle weakness.
• Financial Restructuring — Approximately 19.7% of TTM Revenue:
  • TTM revenue was approximately $503.64M.
  • Quarterly revenue declined approximately 12% YoY to $118.00M in Q2 FY2027.
  • Credit stress, liability management, and restructuring activity can generate countercyclical opportunities, although actual fee recognition remains transaction-dependent.
• Financial and Valuation Advisory — Approximately 14.1% of TTM Revenue:
  • TTM revenue was approximately $360.63M.
  • Q2 FY2027 revenue increased approximately 7% YoY to $93.00M.
  • Valuation services, fairness opinions, and related assignments diversify fee generation beyond traditional M&A transactions.
• Revenue Mix Conclusion: Corporate Finance drives most consolidated revenue and growth potential. Restructuring and valuation advisory provide meaningful diversification, but their combined contribution remains substantially smaller than Corporate Finance.

Q1-A4. Who Are Houlihan Lokey’s Competitors?

• Independent Investment Banking Competitors:
  • Lazard: Competes in M&A and restructuring advisory, particularly through established corporate relationships and international capabilities.
  • Evercore: Competes in high-value independent M&A advisory and strategic financial advice.
  • PJT Partners: Competes in restructuring and strategic advisory, with particularly strong exposure to complex transactions.
  • Moelis & Company: Competes in independent investment banking and restructuring across multiple industries.
• Large Integrated Banks: Goldman Sachs, Morgan Stanley, and JPMorgan compete for major advisory mandates, benefiting from extensive corporate relationships and financing capabilities.
• Middle-Market Specialists: Jefferies, Lincoln International, and other specialist advisory firms compete directly for sponsor-backed and middle-market mandates.
• Competitive Advantages: Houlihan Lokey has established expertise in middle-market M&A, financial restructuring, and complex valuation assignments. Its broad advisory platform supports referrals between practices and provides access to different economic conditions.
• Competitive Limitations: Advisory mandates are contestable, senior bankers can change firms, and successful deal execution does not establish exclusive control over clients.
• Industry Position: Houlihan Lokey is a leading independent financial advisory franchise with particularly strong restructuring capabilities, but it operates in a competitive professional-services industry rather than a protected monopoly.

Q1-A5. Houlihan Lokey Key Events: Past 12 Months

• January 28, 2026 Q3 FY2026 Earnings Release
  • Description: Quarterly adjusted EPS of approximately $1.94 reflected strong advisory activity during the fiscal year. The result demonstrated the firm’s earnings potential when transaction markets remain supportive.
• May 06, 2026 Q4 FY2026 Earnings Release
  • Description: Quarterly revenue reached approximately $635.64M, while adjusted EPS of approximately $1.63 fell below prevailing expectations. The release indicated increased earnings sensitivity to transaction timing.
• July 29, 2026 Q1 FY2027 Earnings Release
  • Description: Revenue declined to approximately $511.00M and adjusted EPS reached approximately $1.35. The result highlighted a substantial slowdown in advisory fee realization, particularly relative to the preceding fiscal year.
• August 03, 2026 Chief Financial Officer Purchased Shares
  • Description: CFO J. Lindsey Alley purchased 4,020 shares at approximately $124.52 per share, representing an investment of approximately $500,571. The open-market purchase provided a positive management-alignment signal during a period of share-price weakness.
• September 10, 2026 General Counsel Reported a Share Sale
  • Description: Christopher M. Crain reported selling 1,000 shares at $140.15 following a share-class conversion. The approximately $140,150 transaction was considerably smaller than the CFO’s August purchase.
• October 28, 2026 Q2 FY2027 Earnings Release
  • Description: Revenue increased approximately 4.9% YoY to $692.00M, with GAAP diluted EPS of $1.64 and adjusted diluted EPS of $1.85. Corporate Finance recovered, while Financial Restructuring declined YoY. Management described improving conditions but remained cautious about external volatility.

Q1-A6. Step 1 Key Takeaways

• Step 1 Summary: Houlihan Lokey is a capital-light independent investment bank with strong middle-market M&A and restructuring franchises. Its diversification and specialist expertise support attractive long-term economics, although the first half of FY2027 exposed significant sensitivity to transaction timing and market conditions.

🏰 Step 2: Houlihan Lokey’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Houlihan Lokey Have a Durable Economic Moat?

• Reputation and Relationships: Advisory clients place substantial importance on execution experience, confidentiality, sector expertise, and trusted relationships. These advantages take years to build and cannot be replicated through financial investment alone.
• Specialized Expertise: Restructuring mandates require detailed knowledge of capital structures, creditor negotiations, legal processes, and distressed-company valuation. Established experience creates meaningful barriers for less specialized competitors.
• Cross-Selling Opportunities: Relationships developed through M&A transactions can generate capital advisory, restructuring, and valuation assignments. This broadens client engagement without requiring an entirely new customer-acquisition platform.
• Pricing Power: Strong reputations and complex mandates support premium advisory fees. Nevertheless, fees are negotiated individually, and competition remains meaningful.
• Moat Constraints: Senior banker departures, relationship concentration, and aggressive competition can weaken the franchise. The business does not possess the contractual switching costs typical of subscription software.
• Conclusion: Houlihan Lokey has a durable reputation-based moat, particularly in specialized financial advisory, but its profitability remains dependent on retaining human capital and maintaining transaction flow.

Q2-A2. Is Houlihan Lokey’s Growth Sustainable?

• Industry Structure and Outlook: Global M&A advisory represents a large, fragmented market influenced by corporate strategic activity, financial sponsor transactions, financing availability, and regulatory conditions. Growth opportunities exist through international expansion, additional advisory teams, and greater penetration of established sponsor relationships.
• Growth Sustainability: FY2026 revenue increased 9.55% to $2.62B, following 24.81% growth in FY2025. However, revenue declined approximately 0.4% on the latest TTM basis, demonstrating that long-term franchise expansion does not prevent pronounced cyclical fluctuations.
• Downside Scenarios:
  • 1 Extended M&A Weakness: Elevated financing costs, policy uncertainty, or reduced private equity exits could delay transaction completion and suppress Corporate Finance revenue.
  • 2 Banker Retention Pressure: Higher compensation demands or the departure of productive senior bankers could erode advisory margins and client relationships.
  • 3 Weakening Restructuring Demand: A simultaneous slowdown in M&A activity and restructuring completions could reduce the diversification benefit from the firm’s advisory practices.

Q2-A3. How Does Houlihan Lokey Allocate Capital & Return Cash?

• Dividends: The current indicated annual dividend is $2.80 per share, yielding approximately 2.03%. The company has maintained a long-standing dividend-growth record, supported by positive earnings and cash generation.
• Share Repurchases: FY2026 repurchases totaled approximately $318.17M, compared with $154.86M in FY2025. Outstanding shares declined approximately 1.6% over the most recent year.
• Total Shareholder Return: The indicated dividend yield and estimated buyback yield combine to approximately 3.7%, below an 8% annual shareholder-return threshold but meaningful alongside reinvestment.
• Strategic Acquisitions: Targeted acquisitions can expand industry coverage, geographic reach, and specialized advisory capabilities. However, goodwill, integration costs, and banker retention require scrutiny.
• Capital Efficiency: Low physical capital expenditure enables substantial discretionary deployment toward dividends, repurchases, acquisitions, and liquidity reserves.
• Allocation Constraint: Equity compensation and banker incentives absorb part of the economic benefit of buybacks; gross repurchase spending should not be confused with equivalent net shareholder value creation.

Q2-A4. Step 2 Key Takeaways

• Scoring Rationale:
  • Economic Moat (9/10): Strong independent advisory reputation, restructuring expertise, and diversified client relationships support high barriers, although banker mobility limits durability.
  • Growth Sustainability (6/8): International and sector expansion support growth, but the recent TTM revenue contraction demonstrates persistent transaction-cycle dependence.
  • Capital Allocation (6/7): Dividends, repurchases, and disciplined capital-light reinvestment are attractive, with equity compensation limiting net buyback effectiveness.
• 📊 Step 2 Score: 21/25 pts (Economic Moat 9/10 + Growth Sustainability 6/8 + Capital Allocation 6/7)
• Step 2 Summary: Houlihan Lokey combines a durable professional-services franchise with shareholder-oriented capital allocation. Its principal limitation is exposure to cyclical advisory demand rather than a lack of competitive capability.

💰 Step 3: Is Houlihan Lokey Profitable? Financial Health Analysis

Q3-A1. Houlihan Lokey’s Growth & Profitability Trends

• Revenue Growth Has Temporarily Slowed: FY2026 revenue reached $2.62B, up 9.55% from $2.39B in FY2025. However, TTM revenue through September 2026 declined to approximately $2.56B, reflecting weaker early-FY2027 transaction activity.
• Operating Profit Remains Substantial: FY2026 operating income was approximately $618.54M, compared with $556.08M in FY2025. TTM operating income declined to approximately $582.54M, resulting in an operating margin of about 22.8%, versus approximately 23.6% in FY2026.
• Net Earnings Moderated: FY2026 net income increased to approximately $425.70M from $399.71M in FY2025. TTM net income declined to approximately $403.70M, while diluted EPS was approximately $5.96 compared with $6.22 for FY2026.
• Quarterly Results Showed a Partial Recovery: Q2 FY2027 revenue increased from $660.00M to $692.00M YoY, but attributable net income declined from approximately $111.00M to $109.00M. Operating income increased from $151.00M to $154.00M, indicating that revenue recovery has not yet translated into strong earnings acceleration.
• Cash Flow Remains Positive but Volatile: FY2025 FCF was approximately $808.91M, declining to $681.82M in FY2026. The latest separately available rolling cash-flow series through June 2026 showed approximately $484.82M, illustrating the impact of working-capital timing and compensation payments.
• Operating Leverage Assessment: Advisory margins are attractive, but near-term operating leverage has been limited because variable compensation, personnel investment, and transaction timing have absorbed part of revenue growth.

Q3-A2. How Profitable Is Houlihan Lokey? (Margins & ROIC)

• Operating Margin: TTM operating margin was approximately 22.8%, compared with approximately 23.6% in FY2026 and 23.3% in FY2025. The relatively narrow range demonstrates resilience despite meaningful fluctuations in revenue.
• Net Profit Margin: TTM net margin was approximately 15.8%, compared with about 16.3% in FY2026. Profitability remains strong for a labor-intensive financial advisory business.
• ROIC and WACC: ROIC was approximately 14.8%, compared with an estimated WACC of 9.3%, producing a positive spread of approximately 5.5 percentage points. The capital-cost estimate depends on market assumptions and should not be treated as a contractual financing rate.
• Return on Equity: ROE was approximately 17.3%, reflecting meaningful profitability relative to book equity.
• Competitive Interpretation: The firm’s profitability is supported by specialized advisory fees and limited physical capital requirements. However, the relevant comparison is with independent advisory firms rather than commercial banks, whose balance-sheet economics differ fundamentally.

Q3-A3. What Drives Houlihan Lokey’s Returns? (ROIC Breakdown)

• Selected Efficiency Indicators: Revenue per employee, compensation expense ratio, and operating margin are the most relevant indicators because advisory revenue is primarily generated by professional teams rather than physical assets.
  • Revenue per Employee: Approximately $912,684 of TTM revenue per employee illustrates the high-value nature of the advisory model. The figure reflects company-wide revenue and headcount rather than individual banker productivity.
  • Compensation Expense Ratio: In Q2 FY2027, compensation expense of $441.00M represented approximately 63.7% of revenue, compared with approximately 64.1% a year earlier. The modest improvement suggests some compensation flexibility as transaction revenue recovers.
  • Operating Margin: Q2 FY2027 operating margin was approximately 22.3%, compared with 22.9% a year earlier. Higher non-compensation expenses offset part of the compensation-ratio improvement.
• Operational Driver: The number and productivity of revenue-generating bankers, transaction completion rates, and the mix of advisory mandates determine revenue productivity and incremental margins.
• Return Driver Conclusion: High professional productivity and relatively limited tangible capital requirements support positive ROIC-WACC spreads, although compensation and transaction volatility prevent frictionless operating leverage.

Q3-A4. Are Houlihan Lokey’s Earnings High Quality?

• Operating Cash Conversion: On the latest separately available rolling cash-flow basis through June 2026, OCF was approximately $500.13M against net income of approximately $405.70M, representing cash conversion of approximately 1.23x.
• Free Cash Flow Conversion: FCF was approximately $484.82M, equivalent to approximately 1.20x net income over that same period.
• Historical Volatility: FY2025 OCF of $848.61M exceeded FY2026 OCF of $704.13M, despite higher FY2026 net income. Compensation settlement timing and receivables materially affect cash generation.
• Stock-Based Compensation: Annual SBC was approximately $201.30M in FY2026, a substantial noncash addition to operating cash flow. This is economically relevant because equity awards can transfer value to employees unless offset by repurchases.
• Quality Assessment: Cash generation is fundamentally positive and supports reported earnings, but volatile working capital and significant SBC mean reported FCF should not be interpreted as fully distributable owner earnings without adjustment.

Q3-A5. Is Houlihan Lokey’s Balance Sheet Healthy? (Debt & Leverage)

• Cash and Debt: Latest compiled balance-sheet data indicate approximately $837.00M in cash and cash equivalents and $494.00M in total debt, resulting in approximately $343.00M of net cash.
• Debt Burden: Total debt represents approximately 0.8x TTM operating income, a manageable operating-earnings reference for a capital-light advisory business. Standard debt/EBITDA is unavailable on a consistently compiled basis.
• Liquidity: The current ratio was approximately 1.58x, indicating current assets exceed current liabilities.
• Interest Coverage: A consistently comparable EBIT-to-interest expense ratio could not be established. The net-cash position and positive operating earnings provide stronger observable evidence of liquidity resilience.
• Refinancing Risk: The available financial position does not suggest near-term dependence on emergency equity financing or a material refinancing crisis.
• Financial Health Conclusion: Liquidity appears sound, allowing the firm to retain bankers, continue ordinary capital returns, and absorb transaction-cycle weakness without excessive financial leverage.

Q3-A6. Step 3 Key Takeaways

• Scoring Rationale:
  • Profitability·Capital Efficiency (9/10): Strong operating margins, ROE, and ROIC above estimated capital costs demonstrate attractive economics despite cyclical earnings.
  • Cash Flow·Profit Quality (5/8): Cash conversion remains positive, but substantial SBC and volatile receivables reduce the reliability of reported FCF as recurring owner earnings.
  • Financial Soundness·Debt Management (6/7): Net cash, positive earnings, and adequate liquidity indicate limited financial distress exposure.
• 📊 Step 3 Score: 20/25 pts (Profitability·Capital Efficiency 9/10 + Cash Flow·Profit Quality 5/8 + Financial Soundness·Debt Management 6/7)
• Step 3 Summary: Houlihan Lokey remains highly profitable and financially resilient. The main financial weakness is the variability of cash conversion and employee compensation rather than excessive leverage.

🔎 Step 4: Houlihan Lokey Forensic Accounting & Dilution Review

Q4-A1. Does Houlihan Lokey Have Accounting Red Flags?

• Revenue recognition: not found
  • Evidence: Advisory revenue is recognized according to contractual performance obligations and applicable accounting requirements. No specific material revenue-recognition violation was established from the reviewed disclosures; transaction timing nevertheless creates normal recognition complexity.
• Cost capitalization: not found
  • Evidence: The firm is not heavily dependent on capitalized manufacturing or development costs. Its expense base is primarily employee compensation and professional-service operating costs.
• Sharp increase in accounts receivable and inventory: not found
  • Evidence: Inventory is not economically material to the business. Accounts-receivable movements remain relevant: FY2026 operating cash flow included an approximately $82.52M cash outflow from receivable changes, versus approximately $21.93M in FY2025.
• Non-recurring adjustment (normalization): discovered
  • Evidence: Q2 FY2027 GAAP diluted EPS of $1.64 differed from adjusted diluted EPS of $1.85. Investors should evaluate the composition and recurrence of adjustment items rather than treating adjusted earnings as equivalent to GAAP earnings.

Q4-A2. Is Houlihan Lokey Overspending? (Capex & Capital Cycle)

• ➖ Not applicable: Houlihan Lokey is a capital-light financial advisory business, not a manufacturing or infrastructure operator exposed to physical-capacity oversupply cycles. The relevant investment and overcapacity risks involve banker hiring, compensation commitments, and competition for advisory mandates rather than plant and equipment expansion.

Q4-A3. How Sound Is Houlihan Lokey’s Cash Flow?

• Positive Operating Cash Flow: FY2026 OCF was approximately $704.13M, comfortably above reported net income of $425.70M.
• Cash Flow Deterioration: OCF declined from $848.61M in FY2025 and the subsequently available rolling period through June 2026 showed further weakness. This warrants monitoring of transaction-related receivables and compensation cash settlements.
• Free Cash Flow Support: FY2026 capital expenditures totaled approximately $22.31M, leaving FCF of approximately $681.82M.
• Financing Dependence: The company generated positive operating cash and did not depend on external financing for routine operating survival.
• Warning Signal Assessment: A decline in cash conversion is evident, but the combination of positive operating cash generation, net cash, and the absence of a sustained operating cash deficit limits immediate financial distress concerns.

Q4-A4. Is Houlihan Lokey Diluting Shareholders?

• ⏪ Confirmed (Past) Dilution: Total shares outstanding decreased approximately 1.63% YoY to 69.42M despite sizable equity compensation. FY2026 repurchases of approximately $318.17M exceeded FY2025 repurchases of $154.86M, supporting a net reduction in shares.
• ⏩ Potential (Future) Dilution & Overhang: FY2026 SBC of approximately $201.30M creates continuing dilution pressure. An October 2026 director grant of 925 restricted shares illustrates ordinary equity compensation. The net effect depends on future share issuance, vesting, and the pace of offsetting repurchases.

Q4-A5. Data Integrity Check

• Period: Income-statement TTM through September 2026 is distinguished from the separately available cash-flow TTM through June 2026 and FY2026 historical figures ➡ (Pass)
• Definition: GAAP net income and EPS are separated from adjusted EPS; FCF is defined as operating cash flow less capital expenditures ➡ (Pass)
• Number of Shares: Approximately 69.42M total outstanding shares are distinguished from the approximately 54.00M publicly traded Class A share count and diluted weighted-average shares used for EPS ➡ (Pass)
• Unit: Financial statements use USD, with amounts consistently expressed in millions or billions and per-share values separately identified ➡ (Pass)
• Single Value Confirmation: The adopted price, TTM accounting figures, reported quarterly results, and fiscal-year definitions are internally reconciled for their stated periods ➡ (Pass)

Q4-A6. Step 4 Key Takeaways

• Scoring Rationale:
  • Accounting anomalies·distortion signals (6/8): No established material accounting irregularity, although adjusted earnings and transaction-related recognition warrant monitoring.
  • Cash flow warning signals (5/7): Cash generation remains positive but has declined materially from FY2025 and is sensitive to working-capital movements.
  • Dilution factors (5/5): Net shares have declined despite equity compensation, demonstrating effective recent dilution offset through repurchases.
• 📊 Step 4 Score: 16/20 pts (Accounting anomalies·distortion signals 6/8 + Cash flow warning signals 5/7 + Dilution factors 5/5)
• Step 4 Summary: The forensic profile is generally sound, with no established severe accounting or dilution problem. The largest monitoring priorities are employee equity compensation, cash conversion, and the recurring nature of adjusted earnings exclusions.

👔 Step 5: Houlihan Lokey Management & Shareholder Alignment

Q5-A1. Can You Trust Houlihan Lokey’s Management? (Guidance Track Record)

• Management Leadership: Scott Adelson leads the company as CEO, supported by experienced financial advisory professionals and a long-established independent banking franchise.
• Earnings Execution: FY2026 demonstrated profitable expansion, but the first quarter of FY2027 produced a substantial earnings shortfall relative to expectations. Q2 FY2027 subsequently recovered to $692.00M in revenue and $1.85 adjusted EPS.
• Communication Discipline: Management characterized the latest market environment as improving while explicitly acknowledging external volatility. This supports a balanced assessment rather than an unconditional recovery forecast.
• Guidance Limitations: Advisory revenue is inherently sensitive to transaction timing, making precise quarterly predictions difficult. Management’s credibility is better evaluated across full market cycles than from isolated quarterly earnings surprises.

Q5-A2. What Are Houlihan Lokey Insiders Doing?

• Confirmed Open-Market Purchase: CFO J. Lindsey Alley bought 4,020 shares on August 03, 2026, at approximately $124.52 per share, representing roughly $500,571 of personal capital committed.
• Confirmed Open-Market Sale: General Counsel Christopher M. Crain sold 1,000 shares on September 10, 2026, at $140.15 per share, generating approximately $140,150.
• Nonmarket Equity Award: Director Thomas Reichert received an award of 925 shares on October 01, 2026. This was a compensation grant, not an open-market purchase.
• Recent Net Flow: The identified August-October open-market transactions represented net purchases of 3,020 shares and approximately $360,421 in net purchase value. This is a verified recent subset rather than a complete reconstruction of all transactions over the preceding twelve months.
• Management Sentiment: The CFO’s direct purchase is a constructive confidence signal. The general counsel’s smaller sale does not independently demonstrate a broad executive bearish view, and the available transactions do not establish a coordinated insider buying cluster.

Q5-A3. Is Houlihan Lokey’s Management Aligned With Shareholders?

• Ownership Structure: Houlihan Lokey has a history of multiple share classes, with Class A shares publicly listed. Share-class arrangements and conversion rights warrant continued review when assessing voting influence and dilution.
• Insider Ownership: Approximately 4.94% insider ownership provides direct financial exposure to shareholder outcomes.
• Compensation Incentives: Equity compensation supports retention of productive employees, but approximately $201.30M in FY2026 SBC is economically significant relative to net income.
• Capital Allocation Alignment: Dividends, repurchases, and net share-count reduction demonstrate attention to shareholder distributions.
• Governance Trade-Off: Retaining highly productive bankers can justify equity awards, but incentive arrangements must generate additional fee revenue and economic profit sufficient to offset dilution.

Q5-A4. Step 5 Key Takeaways

• Scoring Rationale:
  • Management Trust (4/5): Established leadership and balanced recent communication support credibility, although earnings remain difficult to forecast precisely.
  • Insider Trends (4/5): The CFO’s substantial open-market purchase outweighs the identified smaller sale, but evidence of broad executive buying is limited.
  • Governance·Compensation System (3/5): Share ownership and repurchases aid alignment, while material SBC and share-class complexity introduce governance trade-offs.
• 📊 Step 5 Score: 11/15 pts (Management Trust 4/5 + Insider Trends 4/5 + Governance·Compensation System 3/5)
• Step 5 Summary: Management incentives are generally aligned with long-term franchise value, supported by capital returns and the CFO’s recent purchase. However, material equity compensation and advisory-cycle unpredictability require continued scrutiny.

⛵ Step 6: Houlihan Lokey Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Houlihan Lokey Guidance

• Latest Earnings Surprise: Q2 FY2027 adjusted EPS of $1.85 exceeded the approximately $1.63 pre-release estimate, while revenue of $692.00M exceeded the approximately $627.39M forecast.
• Next-Quarter Expectations: Available projections for Q3 FY2027 indicate revenue around $734M-$738M and adjusted EPS approximately $1.93-$1.99, depending on the reporting calendar and estimate compilation.
• Management Comparison: Management expects solid performance for the remainder of the fiscal year but has not provided a directly comparable firm-wide quarterly revenue or EPS midpoint. A numerical guidance-consensus gap therefore cannot be calculated.
• Forecast Direction: FY2027 adjusted EPS expectations of approximately $7.32 sit below earlier estimates near $7.56, despite the latest quarterly beat. The recent improvement in sentiment has not eliminated concerns about full-year earnings durability.
• Analyst Actions: Following October results, several firms raised price targets, including J.P. Morgan from $147 to $153 and Goldman Sachs from $153 to $164. These actions indicate improving near-term sentiment but remain external judgments.

Q6-A2. What Is Houlihan Lokey’s Short Interest?

• Institutional Ownership: Approximately 80.95% of outstanding shares are institutionally held, reflecting significant professional-investor participation.
• Short Interest: Approximately 2.15M shares were reported sold short, equivalent to roughly 4.02% of the public float.
• Days to Cover: Approximately 2.51 days, indicating that outstanding short positions are not unusually large relative to typical trading liquidity.
• Short-Interest Trend: The preceding reported short position was approximately 2.59M shares, indicating a reduction of about 0.44M shares.
• Market Implication: Short positioning does not indicate an extreme bearish consensus or a compelling standalone short-squeeze thesis. Earnings revisions and M&A transaction trends are more important near-term share-price drivers.

Q6-A3. Step 6 Key Takeaways

• Scoring Rationale:
  • Consensus vs Guidance (2/3): The latest earnings beat improved expectations, but a precise guidance gap cannot be established and full-year earnings forecasts have softened.
  • Supply·Short Interest (1/2): Short interest is moderate and declining, although institutional positioning does not establish a strong incremental buying catalyst.
• 📊 Step 6 Score: 3/5 pts (Consensus vs Guidance 2/3 + Supply·Short Interest 1/2)
• Step 6 Summary: Market sentiment has improved following the October earnings recovery, but analysts remain sensitive to the pace of transaction normalization. Short positioning is not an unusually important risk or catalyst.

🚀 Step 7: Houlihan Lokey Catalysts & Price Triggers

Q7-A1. What Could Move Houlihan Lokey Stock? (Top 3 Catalysts)

• 1 Recovery in Corporate Finance Transaction Activity
  • Timing: Q3-Q4 FY2027 and the following fiscal quarters.
  • Success Conditions: Higher M&A completion volumes, improved private equity exit activity, and greater advisory banker productivity lift Corporate Finance revenue beyond the Q2 FY2027 recovery.
  • Failure Risk: Financing volatility, transaction delays, or cautious corporate decision-making suppress fee realization despite healthy announced-deal pipelines.
• 2 Restructuring and Capital Solutions Demand
  • Timing: Over the next 6-12 months.
  • Success Conditions: Complex liability-management transactions, refinancing challenges, and corporate restructuring mandates translate into higher fee-generating completions.
  • Failure Risk: Distressed engagements progress slowly or fail to compensate for a weaker M&A environment.
• 3 Sustained Earnings Recovery With Compensation Discipline
  • Timing: January 2027 estimated earnings release and subsequent quarterly disclosures.
  • Success Conditions: Revenue recovery persists while compensation ratios and non-compensation costs remain controlled, generating stronger operating margins and upward earnings revisions.
  • Failure Risk: Higher personnel costs, acquisitions, and uneven deal timing absorb incremental revenue and prevent sustainable EPS growth.

Q7-A2. Houlihan Lokey’s Earnings Revision Trend

• FY2027 Estimate: Compiled adjusted EPS expectations of approximately $7.32 imply a decline from an earlier estimate around $7.56, a reduction of approximately 3.2%.
• FY2028 Outlook: Available adjusted EPS projections around $8.61 imply approximately 17.6% growth from the FY2027 estimate.
• Quarterly Inflection: Q1 FY2027 adjusted EPS of $1.35 was followed by Q2 adjusted EPS of $1.85, representing a substantial sequential recovery.
• Revision Interpretation: The latest earnings beat and favorable target-price revisions support improving sentiment, but recent annual EPS estimate reductions indicate that a broad, sustained upward earnings revision cycle has not yet been established.
• Monitoring Priority: Subsequent changes to FY2027 and FY2028 EPS estimates will help determine whether October’s recovery represents a durable inflection or merely transaction timing.

Q7-A3. Step 7 Key Takeaways

• Scoring Rationale:
  • Catalyst (6/7): M&A normalization, restructuring opportunities, and operational leverage provide credible, meaningful catalysts over the next year.
  • EPS Trend (2/3): Quarterly earnings recovered and FY2028 growth expectations are favorable, but recent FY2027 estimate reductions constrain conviction.
• 📊 Step 7 Score: 8/10 pts (Catalyst 6/7 + EPS Trend 2/3)
• Step 7 Summary: Houlihan Lokey has identifiable catalysts from improving deal markets and earnings normalization. The strongest confirmation would be sustained advisory revenue growth accompanied by operating-margin expansion and positive EPS revisions.

⚖️ Step 8: Is Houlihan Lokey Fairly Valued? Valuation Analysis

Q8-A1. Houlihan Lokey’s Key Valuation Multiples

• PE Ratio: 23.14x (fairly valued) — based on approximately $5.96 of TTM GAAP EPS.
• PS Ratio: 3.75x (fairly valued) — supported by positive margins and the capital-light advisory model.
• PB Ratio: 4.15x (fairly valued) — reflects the value of an advisory franchise whose economic assets extend beyond book equity.
• P/TBV Ratio: 15.35x (overvalued) — a substantial premium to tangible book value, although this metric understates intangible franchise value.
• P/FCF Ratio: 19.76x (fairly valued) — attractive relative to accounting profitability, subject to cash-conversion volatility.
• P/OCF Ratio: 19.15x (fairly valued) — consistent with positive operating cash generation.
• EV/Sales Ratio: 3.61x (fairly valued) — consistent with strong advisory margins and modest physical capital requirements.
• EV/EBITDA Ratio: N/A (unverifiable)
• EV/EBIT Ratio: N/A (unverifiable)
• EV/FCF Ratio: 19.05x (fairly valued) — incorporates enterprise valuation but remains sensitive to the selected cash-flow period.
• Forward PE: 17.01x (undervalued) — based on compiled forward adjusted earnings, which are stronger than current trailing GAAP earnings.
• PEG Ratio: 2.47x (overvalued) — indicates the growth-adjusted valuation is not exceptionally cheap under the selected forecast convention.
• Scoring Rationale: The company trades at a reasonable trailing earnings valuation and a more attractive forward earnings multiple. Strong profitability, net cash, and relatively low physical capital intensity support a modest positive valuation assessment, although adjustments, SBC, and transaction-cycle uncertainty limit the margin of safety.
• 📌 (1) Axis Q8-A1 Score: +2

Q8-A2. Houlihan Lokey vs Peers: Valuation Comparison

• Multiple selection based on peer comparison: Forward adjusted P/E is the preferred metric because advisory firms differ in leverage, transaction mix, and accounting adjustments. Lazard, Evercore, PJT Partners, and Moelis are relevant peers, but a sufficiently synchronized current forward-EPS peer dataset could not be established for a defensible arithmetic mean.
• Calculation of peer-to-peer deviation rate: N/A — no verified comparable peer mean.
  • 🧮 Calculation Formula: ((Houlihan Lokey Forward P/E 17.01x - Peer Mean N/A) / Peer Mean N/A) × 100 = N/A.
• Scoring Rationale: Differences in restructuring exposure, compensation, earnings normalization, and forecast periods make an unsupported peer average misleading. Without a verified same-period adjusted P/E series, the relative valuation axis receives no adjustment.
• 📌 (2) Axis Q8-A2 Score: 0

Q8-A3. Is Houlihan Lokey Cheap or Expensive vs Its History?

• Comparison Indicators:
  • Selected Metric: Trailing P/E, using five consecutive fiscal-year-end observations from FY2022 through FY2026.
  • Sampling Basis: Five annual fiscal-year-end observations spanning March 2022-March 2026, rather than quarterly valuation observations.
  • Historical Observations: FY2022 13.51x, FY2023 23.62x, FY2024 31.61x, FY2025 28.34x, and FY2026 23.54x.
  • Historical Minimum: 13.51x.
  • Historical Maximum: 31.61x.
  • Current Multiple: 23.14x, as of October 30, 2026.
  • Range Position Calculation: (23.14 - 13.51) / (31.61 - 13.51) × 100 = 53.2%.
• Scoring Rationale: The current trailing P/E is near the middle of the observed annual valuation range. Although the stock has declined substantially from its recent price peak, the historical multiple comparison does not independently establish a deep discount.
• 📌 (3) Axis Q8-A3 Score: 0

Q8-A4. What Growth Is Priced Into Houlihan Lokey? (Reverse DCF)

• Implied Growth Rate: 7.0%
  • 1 Methodology: A simplified equity free-cash-flow reverse DCF compares the current approximately $9.58B equity capitalization with an estimated $485.00M annual starting equity cash-flow base. The model solves for constant annual cash-flow growth over ten years.
  • 2 Core assumptions: The analyst model uses a 10.0% cost of equity, 3.0% perpetual terminal growth, a ten-year explicit forecast, and no separately modeled share issuance. The starting base approximates the latest available annualized operating cash generation after capital expenditure, with the assumption that financing cash flows and employee equity dilution do not materially change the chosen equity-cash-flow reference.
• Achievable Growth Rate: 8.0%
  • Basis: This is an analyst assumption, not management guidance or consensus. It reflects the possibility of medium-term advisory revenue recovery, moderate operating leverage, international franchise growth, and continued client demand, tempered by compensation expense and transaction cyclicality.
• Growth gap and difficulty assessment:
  • 🧮 Formula: Achievable Growth Rate 8.0% - Implied Growth Rate 7.0% = +1.0%p
• Scoring Rationale: Under the stated assumptions, the implied cash-flow growth rate is broadly consistent with a plausible long-term trajectory. The small positive difference does not provide a substantial margin of safety. The cash-flow base includes noncash SBC add-backs, so dilution or additional repurchases could reduce equity-owner returns relative to the simplified model.
• 📌 (4) Axis Q8-A4 Score: 0

Q8-A4-1. What Growth Hurdle Does the Market Demand From Houlihan Lokey? (Reverse DCF Alternative)

• Scoring Rationale: Not applicable — the primary reverse DCF provides a workable conditional equity-cash-flow model using a supported cash-flow starting point and explicitly stated financing and discount-rate assumptions.
• 📌 (4) Axis Q8-A4-1 Score: ➖

Q8-A5. Houlihan Lokey’s Hidden Asset & Stake Valuation

• Scoring Rationale: Not applicable — Houlihan Lokey’s primary economic value comes from its operating advisory franchise, and qualifying separable investment assets or independently valued holdings representing at least 10% of market capitalization have not been established.
• 📌 (5) Axis Q8-A5 Score: ➖

Q8-A6. Final Valuation Adjustment

• Scoring Rationale: The franchise’s reputation, restructuring diversification, and capital-light economics are already reflected in the fundamental profitability and valuation assessments. No separate exceptional valuation factor warrants an additional adjustment.
• 📌 (6) Axis Q8-A6 Score: 0

Q8-A7. Valuation Adjustment Score Calculation

• Calculation Process:
  • (1) Axis (Key Valuation Indicators): +2 pts (Undervalued)
  • (2) Axis (Peer-to-peer deviation rate): 0 pts (N/A vs peers)
  • (3) Axis (Historical Band Position): 0 pts (observed-range position p = 53.2%; Fairly Valued)
  • (4) Axis (Justification for Growth): 0 pts (Achievable growth modestly exceeds conditional implied growth)
  • (5) Axis (Held assets·Share Valuation): 0 pts (Not applicable)
  • (6) Axis (Final adjustment): 0 pts (No independent exceptional adjustment)
• 📊 Valuation Adjustment Score: A1 (+2) + A2 (0) + A3 (0) + A4 (0) + A5 (0) + A6 (0) = +2 pts
• Commentary: Forward valuation appears more attractive than trailing valuation because earnings are expected to recover from a weaker transaction period. Nevertheless, the historical multiple comparison and reverse DCF indicate limited evidence of extreme undervaluation.
• Step 8 Summary: Houlihan Lokey offers modest valuation appeal at the current price, particularly if advisory earnings normalize. The investment case depends more on successful earnings recovery than on an unusually large valuation discount.

💀 Step 9: What Are the Risks of Houlihan Lokey? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Houlihan Lokey?

• 1 Prolonged M&A and transaction-market weakness:
  • Cause: Higher financing costs, macroeconomic uncertainty, regulatory delays, or weak private equity exit activity can reduce completed transactions.
  • Impact: Corporate Finance represents approximately two-thirds of revenue, so weaker deal activity can materially depress fee income and banker productivity.
  • Mitigation/Monitoring Indicators: Monitor quarterly Corporate Finance revenue, announced and completed M&A activity, sponsor transaction trends, and changes in adjusted EPS expectations.
• 2 Senior banker departures and compensation inflation:
  • Cause: Competing investment banks may recruit productive advisory teams by offering guaranteed compensation or substantial equity awards.
  • Impact: Revenue-generating talent losses can damage client relationships, while compensation inflation can reduce operating margins even when transaction activity improves.
  • Mitigation/Monitoring Indicators: Track senior banker retention, compensation-to-revenue ratios, SBC, and operating margin.
• 3 Inconsistent cash conversion and equity compensation:
  • Cause: Advisory receivable collections, compensation settlement timing, and employee equity awards can create divergence between accounting earnings and owner cash flow.
  • Impact: Weaker cash conversion could constrain repurchases and dividends or reduce long-term per-share value creation.
  • Mitigation/Monitoring Indicators: Compare rolling OCF with net income, monitor receivable changes, and assess net share-count movements alongside SBC.

Q9-A2. How Sensitive Is Houlihan Lokey to the Economy?

• 1 Higher Interest Rates (Negative Impact ⬇): More expensive acquisition financing can reduce leveraged buyout feasibility, delay private equity exits, and weaken Corporate Finance revenue.
• 2 Lower Interest Rates (Positive Impact ⬆): Easier financing conditions can improve M&A transaction activity and increase advisory fee opportunities, although reduced financial stress may moderate some restructuring demand.
• 3 Tighter Transaction Regulation (Negative Impact ⬇): More restrictive merger reviews and longer approval processes can delay deal closings and shift recognition of transaction-related advisory fees.

Q9-A3. Houlihan Lokey Pre-Mortem: What Could Go Wrong?

• 1 Global deal activity remains depressed for several years: Financing uncertainty and weak private equity exits cause persistent declines in completed transactions, leaving Corporate Finance unable to recover its historical earnings contribution.
  • Early Warning Signal: Multiple consecutive quarters of weak Corporate Finance revenue accompanied by declining forward adjusted EPS estimates.
• 2 Compensation costs become structurally disconnected from revenue: Competition for senior bankers raises guaranteed pay and equity awards even when transaction fees stagnate.
  • Early Warning Signal: Compensation expense ratios rise persistently while operating margins contract despite stable or recovering revenue.
• 3 The advisory franchise loses its competitive edge: Significant banker departures or weak execution damage relationships with corporate and financial sponsor clients.
  • Early Warning Signal: Sustained loss of senior revenue-generating teams accompanied by falling advisory productivity and weak new mandate activity.

Q9-A4. Risk Adjustment Score

• Reason for Scoring: The firm is materially exposed to advisory transaction cycles, as demonstrated by first-half FY2027 revenue of $1.20B versus $1.27B a year earlier. However, the latest quarter recovered, the firm remains profitable, and its net-cash balance offers financial flexibility. The identified risks are meaningful but have not established a sustained severe impairment of the franchise or its financial stability.
• 📊 Risk Adjustment Score: -4 pts
• Step 9 Summary: Houlihan Lokey’s primary risks involve transaction cyclicality, talent retention, and cash-flow conversion. The franchise remains financially resilient, although recovery in deal activity is essential to sustaining attractive earnings growth.

🎯 Step 10: Houlihan Lokey Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

• Investment Score Calculation Formula:
  • Step breakdown: S2 (21) + S3 (20) + S4 (16) + S5 (11) + S6 (3) + S7 (8) = 79 pts
  • Steps 2-7 Sum (79 pts) + Valuation Adjustment (+2 pts) + Risk Adjustment (-4 pts) = Investment Score 77 pts
• Investment Score & Rating: 77 pts (A Rating ⭐⭐⭐⭐)
  • Commentary: The firm’s established advisory franchise, attractive return on capital, sound liquidity, and shareholder distributions support a favorable fundamental assessment. Modest valuation appeal and credible recovery catalysts outweigh manageable cyclical risks, although volatile transaction revenue and employee compensation limit conviction.

Q10-A2. Should You Buy Houlihan Lokey? (Recommendation)

• Recommendation: Buy
  • Commentary: Houlihan Lokey offers exposure to a high-quality independent financial advisory franchise at a valuation that appears reasonable relative to normalized earnings potential. The investment case depends on continued transaction recovery and disciplined banker compensation rather than unusually rapid structural growth.

Q10-A3. Investment Thesis in One Line

• Houlihan Lokey combines a durable independent advisory franchise, strong profitability, and M&A recovery potential at a reasonable valuation, although cyclical deal activity and compensation costs remain important earnings risks.

Q10-A4. Houlihan Lokey’s Price Trend & Key Drivers

• Stock Price Trend Over the Past 12 Months: Declining With a Recent Recovery 📉↗️ — Shares declined approximately 30.8% over the twelve months ending October 30, 2026, from around $199.29 to $138.00, but recovered approximately 22.3% from the July 30, 2026 52-week low of $112.83.
• July 29, 2026 Q1 FY2027 Earnings Disappointment
  • Description: Revenue of approximately $511.00M and adjusted EPS of $1.35 fell substantially below market expectations, reflecting weaker transaction activity.
  • Stock Price Reaction: Sharp Decline 📉 — Shares weakened around the earnings announcement and reached a 52-week low of $112.83 on July 30, illustrating market concern about earnings sustainability.
• October 28, 2026 Q2 FY2027 Earnings Recovery
  • Description: Revenue increased to $692.00M and adjusted EPS reached $1.85, exceeding expectations. The release improved confidence in a second-half fiscal recovery.
  • Stock Price Reaction: Positive Follow-Through 📈 — Shares closed at $137.38 on October 28 and $139.34 on October 29, compared with $132.35 on October 27, before easing to $138.00 on October 30.

Q10-A5. Action Plan

• Current Price: $138.00
• Buy Zone: $128.00 ($124.00–$132.00)
  • (1) Calculation of Fundamental Value: A conservative entry valuation below the estimated forward earnings value is appropriate given transaction sensitivity and the absence of a substantial historical valuation discount.
  • (2) Momentum Premium/Discount Application: The recovery from July lows and October earnings improvement support avoiding an excessively distant entry target, but the stock has not demonstrated enough sustained earnings momentum to justify paying a significant premium.
  • (3) Conclusion: An entry band of $124.00-$132.00, centered at $128.00, offers a practical discount to the base-case valuation while allowing for ordinary earnings and transaction-market volatility.
• Price Target: $163.59
• Expected Return: +18.5% (vs. current price)
  • 📍 Selected Valuation Metric: FY2028 adjusted diluted EPS multiplied by a normalized forward P/E — appropriate for a profitable, capital-light advisory company whose GAAP earnings are exposed to transaction timing.
  • 🧮 Price Target Calculation Formula: $8.61 FY2028 adjusted diluted EPS × 19.0x P/E = $163.59
  • ⚓ Valuation Basis and Key Assumptions: The approximately $8.61 FY2028 adjusted EPS forecast represents compiled analyst expectations rather than company guidance. A judgment-based 19.0x multiple reflects the firm’s reputation, positive capital returns, and earnings recovery opportunity, balanced against compensation pressure and cyclical transaction demand. The selected multiple is below several recent historical trailing P/E observations, but it applies to later adjusted earnings rather than current GAAP earnings; the lower multiple compensates for forecast and normalization risk. The target is conditional on improved advisory activity and realization of forecast earnings, with revisions to FY2028 EPS representing the principal sensitivity.
• Conditions and timing for reaching price target: Over the next 6-12 months, sustained Corporate Finance recovery and stronger adjusted EPS expectations following the estimated January 2027 earnings release and subsequent quarterly results could support the target multiple and price.
• Stop Loss: $112.00 ($109.00–$115.00)
• Action trigger upon catalyst achievement:
  • 1 Corporate Finance revenue accelerates beyond recent recovery levels
    • Description: Confirm that improved transaction volume is translating into recurring revenue and stronger banker productivity rather than one-off completions. 👉 Maintain Holdings (Hold)
  • 2 FY2028 adjusted EPS expectations rise materially above $8.61
    • Description: Stronger forecasts supported by completed transactions and stable margins would improve the fundamental valuation case. 👉 Consider Additional Buying (Buy)
  • 3 Share price reaches the base-case target without corresponding earnings upgrades
    • Description: Valuation upside would be substantially realized, reducing the prospective return available to new investors. 👉 Take Partial Profits (Sell)
• Action trigger upon risk realization:
  • 1 Corporate Finance revenue contracts for multiple additional quarters
    • Description: Persistent transaction weakness would undermine the assumed earnings recovery and require a lower normalized earnings estimate. 👉 Reduce Holdings (Sell)
  • 2 Compensation ratios rise while operating margins weaken
    • Description: Structural compensation inflation would reduce incremental profitability and weaken the capital-light franchise’s expected earnings power. 👉 Reduce Holdings (Sell)
  • 3 Free cash flow conversion deteriorates materially
    • Description: Persistent weakness in cash conversion alongside rising equity compensation would threaten sustainable shareholder distributions. 👉 Reassess Holdings (Hold)
• Customized Strategy Guide by Investment Preference:
  • Defensive Investors: Favor entry within the lower half of the $124.00-$132.00 band and require evidence of improving earnings forecasts before committing a meaningful position.
  • Neutral Investors: Consider staged purchases around the $128.00 entry midpoint, balancing valuation opportunity against near-term transaction-cycle uncertainty.
  • Aggressive Investors: Small initial positions near the current market price may be considered, with additional exposure conditioned on earnings revisions and operational execution rather than price momentum alone.

🕵️‍♂️ Deep Dive Analysis

Q1: Is Houlihan Lokey’s Dependence on M&A Activity Its Greatest Structural Weakness?

• Analysis: Corporate Finance represents approximately 66% of TTM revenue, making deal activity the dominant driver of consolidated performance. Even an established advisory franchise cannot force transaction completions when financing, valuation, or regulatory conditions deteriorate. Restructuring and valuation advisory provide diversification, but their smaller size limits their ability to fully offset a major M&A downturn.
• Judgment: Negative — Deal-cycle dependence is the firm’s most important structural limitation, although specialization and diversified advisory capabilities mitigate its severity.

Q2: Can Houlihan Lokey’s 17.01x Forward P/E Be Justified by Its Earnings Recovery Prospects?

• Analysis: Forward earnings incorporate expected improvement beyond current TTM GAAP results. The multiple appears reasonable for a profitable, net-cash advisory franchise, particularly if Corporate Finance recovers and operating margins stabilize. However, the historical trailing P/E range and cash-flow sensitivity indicate that this is not an exceptionally discounted stock under every valuation lens.
• Judgment: Fairly Valued to Moderately Undervalued — The price offers attractive conditional upside, but successful execution of the recovery remains necessary.

Q3: Can Houlihan Lokey Sustain Its Competitive Advantage Against Evercore, Lazard, and PJT Partners?

• Analysis: Houlihan Lokey competes through advisory specialization, middle-market relationships, and restructuring experience rather than balance-sheet financing capabilities. Its franchise can remain competitive because complex mandates depend on reputation and execution. Nevertheless, the market for senior advisory talent is highly competitive, creating a persistent threat from rival hiring.
• Judgment: Positive — The firm’s differentiated advisory expertise provides a durable advantage, but banker retention remains crucial to sustaining it.

Q4: Will Houlihan Lokey’s Financial Restructuring Business Offset Future M&A Downturns?

• Analysis: Restructuring advisory can benefit when leveraged companies face refinancing difficulties, offering partial diversification against weaker acquisition activity. However, restructuring revenues declined approximately 12% YoY in Q2 FY2027 even as Corporate Finance recovered. This demonstrates that different advisory segments do not always move in opposite directions.
• Judgment: Neutral to Positive — Restructuring is a meaningful strategic hedge, but it should not be assumed to eliminate consolidated revenue cyclicality.

Q5: Is Houlihan Lokey’s Stock-Based Compensation Too High for Shareholders?

• Analysis: FY2026 SBC of approximately $201.30M represented a meaningful economic cost relative to $425.70M of net income. Although share repurchases have more than offset recent net issuance, those repurchases consume cash that could otherwise increase shareholder distributions or fund acquisitions. The crucial issue is whether equity incentives produce sufficient incremental advisory revenue and retention benefits.
• Judgment: Neutral — Equity compensation is substantial but has not translated into recent net share-count expansion. Continued buyback efficiency is important.

Q6: How Much Operating Leverage Can Houlihan Lokey Generate During an M&A Recovery?

• Analysis: Q2 FY2027 revenue increased approximately 4.9% YoY, but operating income improved only about 2.0%. Compensation expense flexibility provided a partial benefit, while non-compensation expenses increased. Stronger operating leverage would require revenue growth to exceed compensation and infrastructure cost growth consistently over multiple quarters.
• Judgment: Moderately Positive — Incremental margin expansion is achievable, but the latest quarter shows that it is not automatic.

Q7: Does Houlihan Lokey’s Net Cash Position Create a Meaningful Competitive Advantage?

• Analysis: Approximately $343.00M of net cash provides financing flexibility during cyclical downturns. This enables the firm to retain productive teams, pursue acquisitions, and continue capital returns without relying heavily on external borrowing. Its importance lies in resilience and strategic optionality rather than generating exceptional investment income.
• Judgment: Positive — Balance-sheet flexibility improves the firm’s ability to protect its franchise during weak transaction environments.

Q8: Could Private Equity Exit Activity Be the Most Important Catalyst for Houlihan Lokey?

• Analysis: Private equity sponsors represent important advisory clients, and delayed portfolio exits can suppress M&A fee realization. A sustained recovery in exit activity would increase sell-side mandates, financing requirements, and transaction completions. However, higher announced deal volume must ultimately convert into completed transactions before revenue recognition benefits become durable.
• Judgment: Positive — Improving sponsor-backed transaction activity could materially support earnings, provided financing and completion conditions improve.

Q9: Does Houlihan Lokey’s Dividend and Repurchase Program Support Long-Term Per-Share Compounding?

• Analysis: The indicated annual dividend of $2.80 per share produces an approximately 2.03% yield, while recent repurchases have reduced the outstanding share count. These distributions provide tangible shareholder returns. However, annual free cash flow fluctuates substantially, and the economic return from repurchases depends on purchase valuation and the dilution offset required by equity awards.
• Judgment: Positive — Capital returns contribute meaningfully to the investment thesis, although returns on reinvestment and repurchase discipline remain important.

Q10: What Would Invalidate Houlihan Lokey’s Buy Thesis Over the Next Year?

• Analysis: The bullish case assumes that the October 2026 revenue recovery develops into sustained transaction activity, better earnings revisions, and stable advisory margins. Persistent Corporate Finance contraction, significant senior banker departures, or rising compensation ratios without corresponding fee growth would invalidate those operating assumptions. A collapse in cash conversion would create an additional challenge to per-share value creation.
• Judgment: Conditional Positive — The franchise remains attractive, but the next several earnings releases must demonstrate that the recovery is durable rather than an isolated timing benefit.